1Sumer M, Ozdemir I, Erturk O, et al. Progression in acute ischemic stroke : frequency, risk factors and prognosis [ J ] Clin Neurosci,2003,10(2) :1 772 - 1 801.
6Nagano H, Suzuki T, Hayashi M, et al. Effects of a human urinary kininogenase( SK - 827) on cerebral and cutaneous microcirculation in rabbits [ J ]. In Vivo, 1993,7 ( 2 ) : 117 -119.
7Nagano H, Suzuki T, Nakamura S, et al. Pharmacological studies on human urinary kallidinogenase( SK -827) :cerebral protective effects. [ J]. Yakugaku Zasshi, 1993,113 (11) :803 -809.
8Emanueli C, Madeddu P. Angiogenesis therapy with human tissue kallikrein for the treatment of ischemic diseases [ J ]. Arch Mal Coeur,2004,97 ( 6 ) :679 - 687.
9Xia C F, Yin H, Borlongan C V, et al. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis [ J ]. Hypertension, 2004,43 ( 2 ) :452 - 459.
